I was a bit bemused with the reference to JP Morgan.
“These discussions will continue at the upcoming JP Morgan Healthcare Conference in San Francisco in January 2024, in which Starpharma will participate.”
It doesn’t really sit well within an announcement regarding the Docetaxel results. I would expect a separate announcement at the start of the new year outlining the conference participation. Unless… they are giving us all a heads up of an upcoming commercial agreement!!? Will Cheryl be there, first week into the job? Will Jackie be there, watching and learning how to seal a deal?
2024 sounds like a big year. I had better put it in my calendar.
SPL Price at posting:
18.5¢ Sentiment: Hold Disclosure: Held
